For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
Viking Therapeutics Inc (NASDAQ: VKTX) closed the day trading at $24.15 down -5.85% from the previous closing price of $25.65. In other words, the price has decreased by -$5.85 from its previous closing price. On the day, 4.16 million shares were traded. VKTX stock price reached its highest trading level at $24.48 during the session, while it also had its lowest trading level at $23.27.
Ratios:
For a better understanding of VKTX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 33.09 and its Current Ratio is at 33.09. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on February 13, 2025, initiated with a Sector Outperform rating and assigned the stock a target price of $102.
On February 07, 2025, Citigroup started tracking the stock assigning a Neutral rating and target price of $38.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 06 ’25 when Lian Brian sold 194,490 shares for $42.75 per share. The transaction valued at 8,313,601 led to the insider holds 2,366,570 shares of the business.
Mancini Marianna sold 54,215 shares of VKTX for $2,317,599 on Jan 06 ’25. The Chief Operating Officer now owns 374,134 shares after completing the transaction at $42.75 per share. On Jan 06 ’25, another insider, ZANTE GREG, who serves as the Chief Financial Officer of the company, sold 50,309 shares for $42.75 each. As a result, the insider received 2,150,595 and left with 165,259 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VKTX now has a Market Capitalization of 2882737152 and an Enterprise Value of 1809291648.
Stock Price History:
The Beta on a monthly basis for VKTX is 0.81, which has changed by -0.68778276 over the last 52 weeks, in comparison to a change of 0.077997446 over the same period for the S&P500. Over the past 52 weeks, VKTX has reached a high of $82.00, while it has fallen to a 52-week low of $24.41. The 50-Day Moving Average of the stock is -19.93%, while the 200-Day Moving Average is calculated to be -51.28%.
Shares Statistics:
Over the past 3-months, VKTX traded about 4.32M shares per day on average, while over the past 10 days, VKTX traded about 3008750 shares per day. A total of 111.57M shares are outstanding, with a floating share count of 108.95M. Insiders hold about 2.94% of the company’s shares, while institutions hold 73.44% stake in the company. Shares short for VKTX as of 1741910400 were 24214313 with a Short Ratio of 5.61, compared to 1739491200 on 25107403. Therefore, it implies a Short% of Shares Outstanding of 24214313 and a Short% of Float of 28.9.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
